ChemicalBook > Product Catalog >API >Antibiotics >Macrolides >ROKITAMYCIN

ROKITAMYCIN

ROKITAMYCIN Structure
CAS No.
74014-51-0
Chemical Name:
ROKITAMYCIN
Synonyms
M-19-Q;TMS 19Q;Rokital;Rikamycin;Ricamycin;ROKITAMYCIN;T'urimyein H4;ROKITAMYCIN USP/EP/BP;3''-Propionylleucomycin A5;Leucomycin V, 4B-butanoate 3B-propanoate
CBNumber:
CB1388574
Molecular Formula:
C42H69NO15
Molecular Weight:
827.99
MOL File:
74014-51-0.mol
Modify Date:
2023/5/4 17:34:41

ROKITAMYCIN Properties

Melting point 116°
alpha D20 -71° (c = 1.0 in chloroform)
Boiling point 879.3±65.0 °C(Predicted)
Density 1.21±0.1 g/cm3(Predicted)
storage temp. Inert atmosphere,Store in freezer, under -20°C
pka 13.06±0.70(Predicted)
CAS DataBase Reference 74014-51-0

ROKITAMYCIN Chemical Properties,Uses,Production

Description

Rokitamycin is a semisynthetic macrolide antibiotic, closely related to miokamycin(2) both in structure and antimicrobial spectrum.

Pharmaceutical Applications

3″-Propionyl leucomycin A5. A semisynthetic macrolide. Unstable in acid media.
The antibacterial spectrum is identical to that of erythromycin, but it is less active against Gram-positive cocci. It is poorly active against H. influenzae (MIC50 8 mg/L) and Mor. catarrhalis (MIC50 4 mg/L). It displays good activity against Campylobacter spp. (MIC50 0.1 mg/L), L. pneumophila (MIC50 0.1 mg/L) and M. pneumoniae (MIC50 0.003 mg/L). It is active against anaerobes, including some Bacteroides spp. (MIC50 <0.05 mg/L).
After a single oral dose of 600 mg, the peak plasma concentration was 1.9 mg/L after 0.6 h. Oral doses of 5, 10 and 15 mg/kg of a syrup formulation given to children achieved plasma concentrations of 0.26, 0.55 and 0.79 mg/L, respectively, after about 40 min. The half-life is around 2 h.
It is mainly eliminated in the bile; only about 2% appears in the urine. Its major metabolites are leucomycin A7, 10″-OH-rokitamycin (which show some antibacterial activity) and leucomycin V. In healthy adult volunteers, the proportions of rokitamycin and its metabolites in serum 30 min after a single oral dose of 1200 mg were 18% (leucomycin A7), 33% (10″-OH-rokitamycin) and 9% (leucomycin V). The pharmacokinetic behavior is not altered in patients with liver cirrhosis. It is available in Italy and Japan.

ROKITAMYCIN Preparation Products And Raw materials

Global( 22)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CHEMSWORTH +91-261-2397244 New Delhi, India 6707 30 Inquiry
Hangzhou FandaChem Co.,Ltd. 008657128800458; +8615858145714 China 9355 55 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-29-87569265 +86-15319487004 China 2132 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 8331 58 Inquiry
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd 15229059051 China 9976 58 Inquiry
BOSCHE SCIENTIFIC, LLC 732 565 9988 United States 6486 55 Inquiry
AK Scientific, Inc. 650 494 8666 United States 6357 65 Inquiry
kemikalieimport + 45 - 2034 3359 Europe 6699 47 Inquiry
ecochem international chemical broker +45 45 42 34 36 Europe 6385 66 Inquiry

74014-51-0(ROKITAMYCIN)Related Search:

3''-Propionylleucomycin A5 Leucomycin V, 4B-butanoate 3B-propanoate (9CI) Ricamycin TMS 19Q ROKITAMYCIN Leummycin V 4B-bu-tanoate 3 B-propanoate M-19-Q Rikamycin Rokital T'urimyein H4 Leucomycin V, 4B-butanoate 3B-propanoate ROKITAMYCIN USP/EP/BP 74014-51-0